Erectile dysfunction following radiation therapy
ICD-10 N52.35 is a billable code used to indicate a diagnosis of erectile dysfunction following radiation therapy.
Erectile dysfunction (ED) following radiation therapy is a condition that can arise in male patients who have undergone radiation treatment for pelvic cancers, such as prostate cancer. The mechanism behind this dysfunction is primarily vascular and neurogenic, as radiation can damage the blood vessels and nerves that are crucial for achieving and maintaining an erection. Patients may experience varying degrees of ED, ranging from mild difficulties to complete inability to achieve an erection. The onset of symptoms can occur shortly after treatment or may develop gradually over time. The psychological impact of ED can also be significant, affecting the patient's quality of life and mental health. Treatment options may include pharmacotherapy, vacuum erection devices, or penile implants, depending on the severity of the dysfunction and the patient's overall health status. It is essential for healthcare providers to assess the patient's medical history, the extent of radiation therapy, and any concurrent medical conditions that may contribute to erectile dysfunction.
Detailed patient history, treatment records, and follow-up assessments.
Patients presenting with ED post-prostate cancer treatment.
Consideration of other urological conditions that may coexist.
Comprehensive records of radiation therapy, including dosage and treatment area.
Patients undergoing treatment for pelvic malignancies experiencing sexual dysfunction.
Coordination with urology for management of sexual health post-treatment.
Used for patients with severe ED unresponsive to other treatments.
Detailed surgical notes and pre-operative assessments.
Urology specialists must document the patient's treatment history and rationale for surgery.
The primary cause is damage to the blood vessels and nerves involved in penile erection due to radiation exposure during cancer treatment.
